ArticleTranslational lung cancer research2021

Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysis.

Zhirui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.